biote Corp. (BTMD) vs Celularity Inc. (CELU)
A side-by-side comparison of biote Corp. and Celularity Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
BTMD
biote Corp.
$1.18HealthcareDelayed quote: Oct 6, 2026, 2:49 PM EDT
CELU
Celularity Inc.
$1.60HealthcareDelayed quote: Oct 6, 2026, 2:44 PM EDT
Total return — BTMD vs CELU
growth of $100 · dividends reinvested · last 5yBTMD -88.9% (-35.5%/yr)CELU -98.3% (-55.8%/yr)BTMD compounded faster over this window
Log scale — wide-divergence pair
BTMD CELU
BTMD vs CELU: by the numbers
- •BTMD is the larger company ($52M vs $46M market cap).
- •BTMD is profitable (3.19% net margin) while CELU runs a net loss (-375.77%).
- •BTMD grew revenue faster over the past five years (10.52% vs 8.31% CAGR).
Metrics side by side
Valuation
| Metric | BTMD | CELU |
|---|---|---|
| P/E ratio | 10.11 | N/A |
| P/S ratio | 0.28 | 2.44 |
| EV / EBITDA | 9.11 | N/A |
| FCF yield | 37.81% | N/A |
Profitability
| Metric | BTMD | CELU |
|---|---|---|
| Gross margin | 71.46% | 79.62% |
| Operating margin | 18.50% | -230.92% |
| Net margin | 3.19% | -375.77% |
| ROIC | 13.63% | -192.99% |
Growth (annualized)
| Metric | BTMD | CELU |
|---|---|---|
| Revenue CAGR (5Y) | 10.52% | 8.31% |
| EPS CAGR (5Y) | -25.90% | N/A |
| FCF CAGR (5Y) | 3.81% | N/A |
| Total return CAGR (5Y) | -35.12% | -52.57% |
Frequently asked
- Which has grown faster, BTMD or CELU?
- Over the past five years, BTMD grew revenue faster — BTMD at a 10.52% CAGR versus CELU at 8.31%.
- Is BTMD or CELU more profitable?
- BTMD runs the higher net margin — BTMD at 3.19% versus CELU at -375.77%.
- How have BTMD and CELU total returns compared?
- Over the past 5 years, BTMD delivered -35.12% and CELU delivered -52.57% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
biote P/E ratiobiote ROECelularity ROEbiote operating marginCelularity operating marginbiote revenue growthCelularity revenue growthbiote free cash flowCelularity free cash flow
biote & Celularity appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.